Medical News

RSS

SinoFresh, Green Valley Drug enter marketing relationship for Homeopathic Antiseptic Nasal Spray

SinoFresh® HealthCare, Inc., is pleased to announce that its marketing division has secured an agency marketing relationship with Green Valley Drug, the largest medical supplier in Southern Nevada with a significant pharmacy and medical customer base in the western U.S.

3 Jan 2011

PharMerica acquires Lone Star Pharmacy

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, announced today that it has acquired substantially all the assets of Lone Star Pharmacy based in Garland, Texas. Lone Star Pharmacy is a full service pharmacy to long-term care and assisted living facilities primarily in Dallas and Houston.

3 Jan 2011

Repros receives IRB approval for Androxal Phase IIb study in secondary hypogonadism

Repros Therapeutics Inc. today reported it has received Institutional Review Board (IRB) approval to commence the Phase IIb study of Androxal® in men with secondary hypogonadism. The Company has submitted the protocol for FDA comment and plans to begin enrolling subjects in January. Depending on the rate of subject enrollment, Repros hopes to have the study completed before the end of 2011.

3 Jan 2011

KHN video: Health care battles to surge anew in 2011

In this video feature, Kaiser Health News reporters preview some of the big issues coming this year: The GOP's fight to repeal the law and what the party can offer instead; states' efforts to beat back growing Medicaid costs; consumers' troubles affording care (1/3).

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

EDAP reduces outstanding debt by $4.6 million

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.

3 Jan 2011

U.S. Physical Therapy acquires majority interest in 14 clinic physical therapy group

U.S. Physical Therapy, Inc., a leading national operator of outpatient physical therapy clinics, has acquired a majority interest in a 14 clinic physical therapy group located in the Southeast.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

LA Times: Exploring the fairness of wellness incentives

Wanna make a fast buck? Quit smoking. According to the National Business Group on Health, which represents large employers including Wal-Mart and Wendy's, about 68% of its members either offer a discount of several hundred dollars on health insurance premiums to employees who quit smoking, or provide other incentives or penalties to make it happen (Borrell, 1/3).

3 Jan 2011

FDA approves 200 mg formulation of INTELENCE for HIV-1

The U.S. Food and Drug Administration (FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adults with resistance to an NNRTI and other antiretroviral (ARV) agents.

3 Jan 2011

Accuray named to NASDAQ Global Select Market

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market is designated for public companies that meet the highest listing standards in the world, with measures including market value, liquidity and earnings.

3 Jan 2011

Today's Opinions: End-of-life counseling; Rising costs of boomers; Controlling infections in hospitals

Death panels. Government-sponsored euthanasia. Pulling the plug on grandma. Those were just some of the blatantly false terms conservatives threw around last year to scare Congress into stripping a provision out of the health-reform bill that would have allowed Medicare to reimburse doctors for providing voluntary, end-of-life counseling to their patients. The scare tactics worked (1/2).

3 Jan 2011

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

Senesco Technologies, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead drug candidate SNS01-T for treatment of multiple myeloma.

3 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

Cyfluent Chart, Version 2.0 receives Complete EHR certification

Cyfluent, Inc. announced today that Cyfluent Chart, Version 2.0, is 2011/2012 compliant and was certified as a Complete EHR on Friday, November 12, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

3 Jan 2011

Quantum mechanics technique against flu

With the current outbreak of the flu season in Israel, hospitals are reporting overcrowding, and doctors are advising people who have not yet been vaccinated against flu to get their shots.

3 Jan 2011

Labopharm monetizes future royalty payment stream for RYZOLT through subsidiary

Labopharm Inc. today announced that, through its wholly owned subsidiary, Labopharm Europe Limited, it has monetized the expected future royalty payment stream for RYZOLT(TM) (once-daily tramadol).

3 Jan 2011

Invacare completes redemption of outstanding 9¾% Senior Notes due 2015

Invacare Corporation announced today that it has completed the redemption of its outstanding 9¾% Senior Notes due 2015. In total, the Company redeemed $146,000,000 worth of the Senior Notes in the Fourth Quarter of 2010.

3 Jan 2011

Infinity named to NASDAQ Global Select Market

Infinity Pharmaceuticals, Inc. announces that, effective today, it has been named to the NASDAQ Global Select Market tier, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market tier was created in July 2006 for companies that meet the highest listing standards in the world, based on financial and liquidity requirements.

3 Jan 2011

Saint John's Health System and St.Vincent Jennings parter with Indiana Health Information Exchange

Joining a network that includes 19,000 physicians and over 80 hospitals, long-term care facilities and other healthcare organizations, Saint John's Health System and St.Vincent Jennings Hospitals are now part of the Indiana Health Information Exchange (IHIE). The two hospitals are now connected through their participation in IHIE's DOCS4DOCS ® Service.

3 Jan 2011

Medical News

SinoFresh, Green Valley Drug enter marketing relationship for Homeopathic Antiseptic Nasal Spray

PharMerica acquires Lone Star Pharmacy

Repros receives IRB approval for Androxal Phase IIb study in secondary hypogonadism

KHN video: Health care battles to surge anew in 2011

Deceptive food labels lead to increased risk of deadly diseases

EDAP reduces outstanding debt by $4.6 million

U.S. Physical Therapy acquires majority interest in 14 clinic physical therapy group

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

LA Times: Exploring the fairness of wellness incentives

FDA approves 200 mg formulation of INTELENCE for HIV-1

Accuray named to NASDAQ Global Select Market

Today's Opinions: End-of-life counseling; Rising costs of boomers; Controlling infections in hospitals

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Cyfluent Chart, Version 2.0 receives Complete EHR certification

Quantum mechanics technique against flu

Labopharm monetizes future royalty payment stream for RYZOLT through subsidiary

Invacare completes redemption of outstanding 9¾% Senior Notes due 2015

Infinity named to NASDAQ Global Select Market

Saint John's Health System and St.Vincent Jennings parter with Indiana Health Information Exchange

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News